FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1193867007: Talazoparib tosylate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4688927012 Talazoparib tosylate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4688928019 Talazoparib tosylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Talazoparib tosylate (substance) Is a Enzyme inhibitor protein true Inferred relationship Some
Talazoparib tosylate (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Talazoparib tosylate (substance) Is a Polyadenosine 5'-diphosphoribose polymerase inhibitor true Inferred relationship Some
Talazoparib tosylate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Polyadenosine 5'-diphosphoribose polymerase inhibitor (disposition) true Inferred relationship Some
Talazoparib tosylate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Talazoparib (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Talazoparib (as talazoparib tosylate) 1 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Talazoparib tosylate (substance) Inferred relationship Some 1
Product containing precisely talazoparib (as talazoparib tosylate) 250 microgram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Talazoparib tosylate (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start